Fig. 1.
Fig. 1. Treatment overview of GMALL studies 04/89 and 05/93. / AC indicates cytarabine; ASP, asparaginase; CYCLO, cyclophosphamide; HD, high dose; MITOX, mitoxantrone; MTX, methotrexate; VM26, teniposide.

Treatment overview of GMALL studies 04/89 and 05/93.

AC indicates cytarabine; ASP, asparaginase; CYCLO, cyclophosphamide; HD, high dose; MITOX, mitoxantrone; MTX, methotrexate; VM26, teniposide.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal